Targeted corticosteroid injections directly into hair loss patches to suppress inflammation and restore hair growth.
Experiencing patchy hair loss due to alopecia areata? Intralesional Triamcinolone is a targeted treatment that involves injecting a corticosteroid directly into affected areas to reduce inflammation and stimulate hair regrowth. This helps reactivate hair follicles, improve patch coverage, and support gradual hair recovery over time.

Intralesional Triamcinolone Acetonide (ILT) injection is the first-line, gold-standard treatment for localised alopecia areata — an autoimmune condition in which the immune system attacks hair follicles, causing patchy hair loss on the scalp or elsewhere on the body. By injecting a potent corticosteroid directly into the affected patches, the treatment suppresses the localised immune attack on the follicles, allowing them to resume normal hair production. Unlike systemic (oral) steroids, intralesional delivery concentrates the anti-inflammatory effect precisely at the site of follicle damage while minimising systemic side effects. ILT is most effective for limited, patchy alopecia areata and is typically administered in a series of sessions until adequate hair regrowth is achieved.
This treatment is most appropriate for patients with limited, patchy alopecia areata affecting isolated areas of the scalp, eyebrows, or beard. It is most effective when patches are recent and the follicles have not been dormant for an extended period. Patients with extensive or rapidly progressing alopecia areata, alopecia totalis (complete scalp hair loss), or alopecia universalis (total body hair loss) may require additional or alternative systemic treatments. A dermatologist assessment determines disease extent and treatment suitability.
Intralesional corticosteroid delivery offers highly targeted suppression of the autoimmune inflammation driving follicle damage, enabling regrowth in the affected patches without the side effects associated with oral steroids. When initiated promptly after onset, ILT often leads to significant regrowth within two to three months of treatment. The treatment is quick, well-tolerated, and can be repeated until adequate regrowth is achieved.
No specific preparation is required before the injection sessions. Inform your dermatologist of any systemic medical conditions, current medications, or history of hypersensitivity to corticosteroids. Patients with active scalp infections in the treatment areas may need these resolved before ILT can proceed.
A fine needle is used to inject diluted triamcinolone acetonide solution into multiple points within each alopecia patch, spaced approximately 1 cm apart. The procedure takes 15–20 minutes depending on the number and size of patches being treated. A mild stinging sensation and temporary skin blanching at injection sites are normal. No anaesthesia is typically required, though a topical numbing cream can be applied for comfort.
There is no specific post-treatment restriction. The injection sites may feel mildly tender for a day or two. Avoid vigorous scalp massage in the treated areas for 24 hours. Continue any other prescribed treatments for alopecia areata — such as topical immunotherapy, minoxidil, or systemic therapy — as directed. Follow-up appointments to assess regrowth and plan further injections are scheduled at four to six week intervals.
Intralesional triamcinolone is a well-established and safe treatment for alopecia areata when administered by an experienced dermatologist. Temporary skin indentation (atrophy) at injection sites can occur, particularly with higher concentrations, but is usually reversible. Mild post-injection tenderness and temporary blanching are expected. Systemic corticosteroid effects are minimal due to the small localised doses used.
The cost per session depends on the number and size of patches being treated. Multiple sessions are typically required to achieve satisfactory regrowth. A personalised treatment plan and cost estimate will be provided at your consultation with Dr. Rajat Kandhari.
Experiencing patchy hair loss from alopecia areata? Book a consultation with Dr. Rajat Kandhari for Intralesional Triamcinolone treatment in Delhi — the gold-standard dermatology procedure that targets immune-driven follicle damage directly at the site of hair loss. With expert assessment, precise injection technique, and a personalised management plan, Dr. Kandhari provides comprehensive, clinically proven care for alopecia areata.
Alopecia areata is an autoimmune condition in which the immune system mistakenly attacks hair follicles, causing patchy, non-scarring hair loss on the scalp or other areas of the body.
The corticosteroid is injected directly into the affected patch to suppress the localised autoimmune inflammation, allowing the follicles to recover and resume hair production.
Sessions are typically spaced four to six weeks apart. The number of sessions depends on the size and response of the patches — most patients require three to six sessions to achieve adequate regrowth.
A mild stinging sensation is expected during injection. A topical numbing cream can be applied before the procedure for patients who are more sensitive.
Early regrowth is often visible within six to eight weeks of starting treatment, with significant regrowth typically apparent after two to three sessions.
Yes. When administered by a trained dermatologist at appropriate concentrations, intralesional triamcinolone is safe with minimal systemic effects. The main localised risk is temporary skin atrophy at injection sites.
ILT is most effective for limited, patchy alopecia areata. Extensive or widespread forms typically require additional systemic treatments. Your dermatologist will advise on the most appropriate management approach.
Dr. Rajat Kandhari is an experienced board-certified dermatologist with specialist expertise in diagnosing and managing alopecia areata across its spectrum of presentations, providing evidence-based, personalised treatment plans for each patient.
WhatsApp us